Annie Kruger

Sep 29, 2020 | Trainee Corner

The KL2 Program this year is participating in a newly launched CTSA Visiting Professorship Program. This is an opportunity for Scholars who are in their second or third year of the KL2 Program to virtually visit a CTSA institution and give a Grand Round presentation, which will be advertised across the CTSA nationally. This program provides KL2 Scholars with an opportunity not only to give a national presentation, but also to meet with Faculty from the institution and expand their professional networks. Mount Sinai will be hosting Annie Kruger, MD, PhD from Georgetown University in early 2021.

Annie Kruger, MD, PhD is an Assistant Professor of Medicine in the Department of Gastroenterology at Georgetown University Medical Center and a second-year KL2 Scholar in the Georgetown and Howard Universities Center for Clinical and Translational Science (GHUCCTS) KL2 Program. Her research focuses on the effects of chemokine receptors 2 and 5 in influencing the pro-inflammatory and pro-fibrogenic activity of hepatic macrophages and stellate cells, in non-alcoholic steatohepatitis (NASH), a prevalent metabolic liver disease in the world today. She has had a long-standing interest in studying the innate immune response to infectious and inflammatory conditions including Dengue fever, hepatitis C, hepatitis B, type 1 diabetes, and NASH. Her research efforts have been shaped by her prior industry experience as a pharmaceutical and managed care consultant. Dr. Kruger received her training from the Harvard School of Public Health, the University of Massachusetts Medical School, and Massachusetts General Hospital prior to joining Georgetown University. Her mentors are Fung-Lung Chung, PhD (Professor, Department of Oncology) and Jill Smith, MD, (Professor, Department of Medicine) at Georgetown University.

ConduITS is supported by NCATS of the NIH’s CTSA Program. Any use of CTSA-supported resources requires citation of grant number UL1TR001433 awarded to ISMMS in the acknowledgment section of every publication resulting from this support. Adherence to the NIH Public Access Policy is also required.

 

Recent ConduITS News

What does the Innovation Core do?

Mount Sinai’s Innovation Core is designed to fill the gap in the training and expertise needed to move a discovery from the research setting into a commercially viable product, or to recognize the potential for commercialization. i3 Prism i3 Prism is an early-stage...

read more

What is the Innovation Core?

Mount Sinai’s Innovation Partners (MSIP) is the technology commercialization arm of the Mount Sinai Health System, responsible for driving the real-world application of Mount Sinai discoveries and inventions, and the development of research partnerships with industry....

read more

Newsletter Special Edition

Click here to view the special edition of the Conduit Newsletter, designed in CANVA! As part of a new initiative by The Mount Sinai ConduITS Institutes for Translational Sciences (CTSA), we are thrilled to introduce our latest newsletter designed to aid researchers in...

read more

Trainee Corner

Mount Sinai CTSA Featured Trainees

Megan Januska

Megan Januska

Megan Januska, MD is an Assistant Professor in the Division of Pediatric Pulmonology in the Jack and Lucy Clark Department of Pediatrics and in the Department of Genetics and Genomic Sciences at the Icahn School of Medicine at Mount Sinai and Mount Sinai Kravis...

read more
Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil

Sangeetha Vadakke-Madathil, PhD, is currently a junior faculty (Instructor of Medicine) at Icahn School of Medicine at Mount Sinai, New York, NY. After receiving her Ph.D. degree in human hematopoietic stem cells and transplant biology from National Centre for Cell...

read more